Efficacy of the Endoscopic Ultrasound-first Approach in Patients with Suspected Common Bile Duct Stone to Avoid Unnecessary Endoscopic Retrograde Cholangiopancreatography

Por Maruta, Akinori, Iwashita, Takuji, Uemura, Shinya, Yoshida, Kensaku, Yasuda, Ichiro, Shimizu, Masahito
Publicado no Intern Med (2019)

EUS-guided hybrid rendezvous technique as salvage for standard rendezvous with intra-hepatic bile duct approach

Por Iwashita, Takuji, Uemura, Shinya, Yoshida, Kensaku, Mita, Naoki, Tezuka, Ryuichi, Yasuda, Ichiro, Shimizu, Masahito
Publicado no PLoS One (2018)

Endoscopic ultrasound-guided fine-needle aspiration of pelvic lesions via the upper and lower gastrointestinal tract approaches

Por Mita, Naoki, Iwashita, Takuji, Senju, Akihiko, Ichikawa, Hironao, Iwasa, Yuhei, Uemura, Shinya, Yasuda, Ichiro, Shimizu, Masahito
Publicado no BMC Gastroenterol (2021)

A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer

Por Yoshida, Kensaku, Iwashita, Takuji, Uemura, Shinya, Maruta, Akinori, Okuno, Mitsuru, Ando, Nobuhiro, Iwata, Keisuke, Kawaguchi, Junji, Mukai, Tsuyoshi, Shimizu, Masahito
Publicado no Oncotarget (2017)

Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure

Por Mita, Naoki, Iwashita, Takuji, Uemura, Shinya, Yoshida, Kensaku, Iwasa, Yuhei, Ando, Nobuhiro, Iwata, Keisuke, Okuno, Mitsuru, Mukai, Tsuyoshi, Shimizu, Masahito
Publicado no J Clin Med (2019)

Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy

Por Yamada, Yunami, Fujii, Hironori, Watanabe, Daichi, Kato-Hayashi, Hiroko, Ohata, Koichi, Kobayashi, Ryo, Ishihara, Takuma, Uemura, Shinya, Iwashita, Takuji, Shimizu, Masahito, Suzuki, Akio
Publicado no Cancers (Basel) (2018)